Gene · 7850
Papers2,718
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,718
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluating the role of serum IL1R2 as a biomarker for diagnosis and prognostic stratification in sepsis. | Eur J Med Res | 2026 | 41622254 | PubTator, text mining | PubMed |
| Age- and Genotype-Associated Specific Expression of IL-1 and TNF Receptors on Immunocompetent Cells. | Int J Mol Sci | 2026 | 41596456 | PubTator, text mining | PubMed |
| Latent tuberculosis infection in high TB disease burden countries dysregulates cellular and immunological profiles which is further enhanced with uncontrolled hyperglycemia. | Sci Rep | 2026 | 41565868 | PubTator, text mining | PubMed |
| OLink proteomic biomarker to predict clinical efficacy of Macaranga sinensis Müll.Arg: A nested case-control study. | J Ethnopharmacol | 2026 | 41558579 | PubTator, text mining | PubMed |
| Macrophage-associated immune-stromal crosstalks correlate with the tumor microenvironment in microsatellite-stable mucinous colorectal cancer. | Pathol Res Pract | 2026 | 41558251 | PubTator, text mining | PubMed |
| PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2026 | 41556358 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular basis and therapeutic advances. | Signal Transduct Target Ther | 2026 | 41526343 | PubTator, text mining | PubMed |
| Illustrating the functional heterogeneity of M-MDSCs to predict sepsis outcomes. | J Adv Res | 2026 | 41490841 | PubTator, text mining | PubMed |
| Structural truncation of IL-1R2 enhances the anti-inflammatory activity of HeLa cells. | Cell Struct Funct | 2026 | 41391869 | PubTator, text mining | PubMed |
| VNN2 and IL1R2 Identified as Potential Molecular Signatures in Granulosa Cells and Blood of Patients with Polycystic Ovary Syndrome (PCOS). | Endocr Metab Immune Disord Drug Targets | 2026 | 41114485 | PubTator, text mining | PubMed |
| Characterization of Tumor Microenvironment and Prognosis of Regulatory T cells-Related Subtypes. | Curr Med Chem | 2026 | 40653841 | PubTator, text mining | PubMed |
| Designing and Evaluation of a Novel IL-1RA Fusion Cytokine to Enhance the Pharmacokinetics and Receptor Affinity for Better Therapeutic Intervention in Inflammatory Disorders. | Curr Comput Aided Drug Des | 2026 | 40045854 | PubTator, text mining | PubMed |
| Evidence for Maternal Autoantibodies in the Pathogenesis of Preterm Birth. | medRxiv | 2025 | 41568202 | PubTator, text mining | PubMed |
| Single-cell atlas of COVID-19 based on multiple sample integration. | Medicine (Baltimore) | 2025 | 41465968 | PubTator, text mining | PubMed |
| Interleukin-1 Signalling Inhibitors in Heart Failure With Preserved and Reduced Ejection Fraction. | Kardiologiia | 2025 | 41457842 | PubTator, text mining | PubMed |
| Identification of diagnostic and prognostic biomarkers for tuberculosis based on plasma proteomics. | PLoS One | 2025 | 41428679 | PubTator, text mining | PubMed |
| Structural and dynamic properties of IL1 receptors. | Front Immunol | 2025 | 41415279 | PubTator, text mining | PubMed |
| Interpretable machine learning applied to high-dimensional salivary proteomics accurately classifies pediatric inflammatory bowel diseases. | medRxiv | 2025 | 41282744 | PubTator, text mining | PubMed |
| Humoral immune activation within tertiary lymphoid structures is correlated with poor outcomes in oral lichen planus and lichenoid lesions. | Front Immunol | 2025 | 41200175 | PubTator, text mining | PubMed |
| Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics. | Front Immunol | 2025 | 41181158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7850/papers?page=3